The Death (or Rebirth) of Aspirin in Primary Prevention Abstract The role of aspirin in primary prevention of cardiovascular disease has undergone substantial reassessment over the past decade as emerging evidence has challenged long standing assumptions regarding its routine use in individuals without established cardiovascular disease. For many
Tag: aspirin
Aspirin Dosing Considerations In Essential Thrombocythemia: The ARES Trial
Aspirin Dosing Considerations In Essential Thrombocythemia: The ARES Trial Overview In patients diagnosed with essential thrombocythemia (ET), the standard treatment involves once-daily low-dose aspirin to mitigate the risk of thrombosis. However, due to accelerated platelet turnover in these patients, the antiplatelet effect of aspirin diminishes over time. A study called the Short-term
